What the biopsy report needs to state before a treatment discussion
A prostate biopsy report is not a single result. It is a structured pathology document, and the parts that matter for an overseas treatment decision are often spread across several pages. The first question is what was sampled: which areas of the prostate were biopsied, how many cores were taken from each area, and whether the sample came from a targeted region or a systematic grid. A report that lists only a final diagnosis without this mapping leaves the receiving clinician unable to judge how representative the result is.
The second question is grade. Most pathology reports use the Gleason scoring system, now often expressed as a Grade Group. The report should state the primary and secondary Gleason patterns, the total score, and the Grade Group. If the report gives only a total score without the pattern breakdown, or only a Grade Group without the underlying score, the receiving team may need the full pathology text rather than the summary line.
The third question is extent. The report should describe whether cancer was found in one core or several, whether it appears on one side or both sides of the prostate, and whether any core shows cancer approaching or at the edge of the sample. These details influence how a surgeon or radiation oncologist thinks about the case, but they do not by themselves determine treatment. The treating team decides what the findings mean for an individual patient.
A practical step is to request the full pathology report, not just the conclusion paragraph. If the report is in a language other than English, ask whether a certified translation is available or whether the receiving hospital will arrange interpretation. Do not assume that a translated summary replaces the original document; the original slides and report are what a pathologist would review.
What prostate imaging should show and what it cannot confirm
Prostate imaging, such as multiparametric MRI, serves a different purpose from biopsy. It shows the anatomy of the prostate and surrounding tissue, and it can identify areas that warrant targeted sampling. The report should state the type of scan performed, the date, whether contrast was used, and the radiology impression in clear terms. If the report describes a suspicious lesion, it should say where the lesion is located and how it relates to the biopsy findings.
Imaging and biopsy are complementary, not interchangeable. A scan can suggest that cancer is confined to the prostate or that it may extend beyond the capsule, but it cannot confirm the grade of the cancer or replace tissue diagnosis. A biopsy can confirm grade and extent within the sampled areas, but it cannot show the whole prostate. When the two reports disagree, the treating team needs both documents and may request additional review.
For an overseas patient, the practical question is whether the imaging was performed with a protocol that the receiving hospital can interpret. Some hospitals prefer to repeat imaging with their own equipment and radiologists. That is a clinical decision, not an administrative preference, and it should be discussed with the treating team rather than assumed. Ask whether the existing images are sufficient or whether repeat imaging is likely to be requested.
If you have had imaging at more than one facility, collect the actual image files, not only the written reports. Reports describe findings; images allow a radiologist to review the primary data. The receiving hospital may ask for DICOM files on a disc or through a secure transfer method. Confirm the format and delivery method with the hospital before sending anything.
Previous treatment changes what the report needs to clarify
If you have already received treatment for prostate cancer, the diagnosis report alone is not enough. The receiving team needs a clear timeline of what was done, when, and with what result. This includes any surgery, radiation, hormone therapy, chemotherapy, or focal therapy such as HIFU or cryotherapy. For each treatment, the report should state the date, the treating facility, and the documented outcome.
Previous treatment affects how biopsy and imaging findings are interpreted. Scar tissue from surgery or radiation can change the appearance of the prostate on imaging and can make biopsy sampling more difficult. A pathologist reviewing a post-treatment biopsy needs to know what treatment preceded it, because treatment effects can mimic or mask cancer. If this history is missing, the receiving pathologist may not be able to give a reliable opinion.
The practical step is to prepare a one-page treatment chronology. List each treatment, the date, the hospital, and the documented result. Attach the relevant discharge summaries and pathology reports. If you do not have a document, say so rather than leaving the item blank. The receiving team can then tell you what they need and whether they can proceed without it.
Do not assume that a previous treatment rules out further options, and do not assume that it leaves all options open. That assessment belongs to the treating team after they review the full record. The purpose of the chronology is to give them the facts they need to make that assessment.
Cancer control and function goals belong in the same conversation
Prostate cancer treatment decisions involve two sets of goals that can pull in different directions. One is cancer control: removing or controlling the cancer, and reducing the risk of recurrence. The other is function: urinary continence and sexual function. These goals are not separate conversations. They are part of the same decision, and the weight a patient gives to each is individual.
The diagnosis report informs the cancer-control side of that discussion. It tells the treating team what is known about grade, extent, and prior treatment. It does not tell them what the patient values. That information comes from the patient, and it should be stated clearly before a treatment plan is proposed.
A useful preparation step is to write down your own priorities in plain language. For example: how important is avoiding urinary symptoms, how important is preserving sexual function, and how do you weigh those against the possibility of needing additional treatment later. You do not need to use medical terms. The treating team can translate your priorities into clinical options.
Ask the treating team how each proposed option is expected to affect both cancer control and function, and what is known about those effects in cases similar to yours. Ask what the alternatives are and what happens if you choose to delay a decision. These are questions for the clinician, not questions this article can answer for an individual case.
What a records-based review can and cannot establish
A records-based review, whether through a proxy consultation or a multidisciplinary review, can clarify what the existing documents show and what information is missing. It can identify whether the pathology report is complete, whether the imaging is adequate for interpretation, and whether the treatment history is documented. It can also indicate what additional records the receiving hospital is likely to request.
A records-based review does not establish hospital acceptance, final eligibility for a specific procedure, or a treatment plan. Those decisions require the treating hospital and licensed clinicians to assess the patient, and in many cases they require additional tests or an in-person consultation. A review is a planning step, not a substitute for clinical assessment.
For a patient considering care in China, the practical value of a review is that it can reduce avoidable travel. If the records are incomplete, the review can identify the gap before you book flights. If the records are complete, the review can help match the case to a suitable specialty and prepare questions for the consultation.
The scope and fee of any review should be agreed in writing before it begins. Ask what documents will be reviewed, who will review them, and what the output will be. Do not assume that a review includes a treatment recommendation or a guarantee of hospital acceptance.
Preparing the record for a China consultation
The goal of preparation is to give the receiving team a complete, readable record that supports a clinical decision. Start with the pathology report: the full report, not only the conclusion. Add the imaging reports and the actual image files if available. Add a treatment chronology if there has been prior treatment. Add recent blood tests, including PSA results with dates, and any other investigations the treating team has requested.
Organise the documents in a logical order and label them clearly. A short cover sheet listing the contents helps the receiving team navigate the file. If documents are in another language, include a translation or ask the hospital whether translation will be arranged. Do not send original documents; send copies and keep the originals with you.
Before sending records, confirm with the hospital or coordination service what format they accept and how they prefer to receive it. Do not send passport numbers, payment details, or a complete medical archive in an initial enquiry. A brief summary of the diagnosis and the main question is enough to start.
The next step is to request a free initial case review. This is a non-clinical check of the available records and the patient's main question. It identifies missing information and suggests a relevant next step. It does not establish eligibility or hospital acceptance, and it does not replace a consultation with a treating clinician. You can begin with a short summary through the enquiry form, email, or WhatsApp, and share fuller records after first contact.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.